Bioventus Depreciation And Amortization from 2010 to 2024
| BVS Stock | USD 6.69 0.09 1.33% |
Depreciation And Amortization | First Reported 2015-03-31 | Previous Quarter 12.5 M | Current Value 11.8 M | Quarterly Volatility 4 M |
Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus main balance sheet or income statement drivers, such as Depreciation And Amortization of 41.5 M, Interest Expense of 42.7 M or Total Revenue of 386.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 5.0E-4 or PTB Ratio of 1.81. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
Bioventus | Depreciation And Amortization |
Latest Bioventus' Depreciation And Amortization Growth Pattern
Below is the plot of the Depreciation And Amortization of Bioventus over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Bioventus' Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.
| Depreciation And Amortization | 10 Years Trend |
|
Depreciation And Amortization |
| Timeline |
Bioventus Depreciation And Amortization Regression Statistics
| Arithmetic Mean | 34,169,953 | |
| Geometric Mean | 32,568,839 | |
| Coefficient Of Variation | 36.24 | |
| Mean Deviation | 8,510,065 | |
| Median | 29,238,000 | |
| Standard Deviation | 12,384,405 | |
| Sample Variance | 153.4T | |
| Range | 42.3M | |
| R-Value | 0.75 | |
| Mean Square Error | 72.7T | |
| R-Squared | 0.56 | |
| Significance | 0 | |
| Slope | 2,071,725 | |
| Total Sum of Squares | 2147.2T |
Bioventus Depreciation And Amortization History
About Bioventus Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bioventus income statement, its balance sheet, and the statement of cash flows. Bioventus investors use historical funamental indicators, such as Bioventus's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Bioventus investors may use each financial statement separately, they are all related. The changes in Bioventus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bioventus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bioventus Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bioventus. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Depreciation And Amortization | 57.4 M | 41.5 M |
Pair Trading with Bioventus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioventus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioventus will appreciate offsetting losses from the drop in the long position's value.Moving against Bioventus Stock
| 0.61 | DYNT | Dynatronics Fiscal Year End 26th of September 2024 | PairCorr |
| 0.54 | FNA | Paragon 28 | PairCorr |
| 0.48 | WST | West Pharmaceutical | PairCorr |
The ability to find closely correlated positions to Bioventus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioventus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioventus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioventus to buy it.
The correlation of Bioventus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioventus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioventus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioventus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bioventus Correlation against competitors. For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Bioventus Stock analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Revenue Per Share 8.303 | Quarterly Revenue Growth 0.087 | Return On Assets 0.0152 | Return On Equity (0.12) |
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.